论文部分内容阅读
慢性动脉闭塞症包括血栓闭塞性脉管炎(ＴＡＯ)和闭塞性动脉硬化症(ＡＳＯ)。属中医学“脱疽”范畴,病因尚不完全明了,治疗上有一定困难,预后不好,往往有丧失劳动能力的可能性,给患者带来极大的痛苦。我们自1997年5月起联合使用静脉注射前列腺素Ｅ1脂肪乳注射液(ＬｉｐｏＰＧＥ1
Chronic arterial occlusive disease includes thromboangiitis obliterans (TAO) and arteriosclerosis obliterans (ASO). It belongs to the category of “glancing” by traditional Chinese medicine. The cause of the disease is not completely understood. There are some difficulties in treatment. The prognosis is not good, and there is often the possibility of losing the ability to work to bring great suffering to patients. Since May 1997 we have been using intravenous prostaglandin E1 lipid emulsion injection (LipoPGE1